Abstracts Archive - Page 672 of 1554 - MDS Abstracts

MDS Virtual Congress 2020
Patients’ perspectives on shared decision-making in Parkinson´s disease
E. Gülke, C. Wargel, A. Rahn, A. Solari, C. Buhmann, C. Gerloff, C. Heesen, M. Pötter-Nerger (Hamburg, Germany)
Objective: The aim of this study was to assess Parkinson’s disease (PD) patients’ preferences on how to take medical decisions. Background: Patients’ decisions are mainly…
MDS Virtual Congress 2020
Care-giver Burden in Parkinson’s Disease and Atypical Parkinsonism in Indian Patients Using Zarit Burden Interview scale
D. Hoskere Sreenivasa, M. Philip, P. Kukkle (Bangalore, India)
Objective: To assess the impact of Parkinson’s disease (PD) and atypical-parkinsonism (AP) on primary care giver among Indian population using Zarit Burden Interview (ZBI) scale.…
MDS Virtual Congress 2020
The impact of anxiety on social functioning in Parkinson’s disease
K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)
Objective: To identify factors associated with social functioning in Parkinson’s disease (PD). Background: PD frequently impedes activities of daily living including social functioning [1,2]. Impairments…
MDS Virtual Congress 2020
Concerns in patients with Parkinson’s disease in China: A content analysis of data from social listening
Y. Qian, X. Yang, S. Xu, X. He, Y. Zhang, C. Mo, Q. Xiao (Shanghai, China)
Objective: To understand Parkinson’s disease (PD) patients’ unmet needs and optimize the communication strategy with them, we used social media listening (SML) to focus on…
MDS Virtual Congress 2020
Longitudinal association between UPDRS and health-related quality of life in people with Parkinson´s disease
A. Reyes, L. Rutten-Jacobs, S. Roumpanis, S. Jauss, P. Coloma (Basel, Switzerland)
Objective: To investigate the longitudinal association of the UPDRS part I (mentation, behavior and mood), UPDRS part II (patient evaluation of activities of daily living…
MDS Virtual Congress 2020
Health care provision and health related quality of life in late stage Parkinson’s disease
K. Rosqvist, P. Odin, A. Schrag (Lund, Sweden)
Objective: To describe and assess factors associated with health related quality of life (HRQoL) in late stage Parkinson’s disease (PD), with a special focus on…
MDS Virtual Congress 2020
The Care Partner Perspective: Most Challenging Parkinson’s Symptoms
A. Wallis, D. Perret (Miami, FL, USA)
Objective: Our objective is to understand the impact that specific symptoms have on the care partners of people with Parkinson’s, considering gender (of both the…
MDS Virtual Congress 2020
Wilson and Parkinson’s Disease: Beyond Copper Metabolism
B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Masjuán Vallejo, J.C Martínez Castillo, A. Celdrán, J. Vaamonde Gamo, J.P Cabello, D. Burgos Santamaría, G. Sánchez Díez, I. Parées Moreno, G. Garcia-Ribas, A. Alonso Cánovas (Madrid, Spain)
Objective: To show an unusual presentation of Wilson´s disease. Background: Parkinsonism is evident in approximately 40% of patients with Wilson’s disease and responds favourably to…
MDS Virtual Congress 2020
Olfactory impairment in Wilson’s disease
L.i Chen, X. Wang (Tianjin, China)
Objective: Olfactory dysfunction is a very common and early sign of many neurodegenerative disorders, but little is known about olfactory dysfunction in Wilson’s disease (WD).…
MDS Virtual Congress 2020
Cerebrotendinous Xanthomatosis Tremor Successfully Controlled post-VIM-Deep Brain Stimulation
S. De Jesus, J. Davanzo, J. McInerney, E. Farace (Hershey, PA, USA)
Objective: Report on tolerability of VIM-deep brain stimulation (DBS) in a patient with cerebrotendinous xanthomatosis (CTX) and medication refractory unilateral tremor. Background: CTX is a…